Catalyst Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | +2,389.7% | +131.7% | +7.1% | -2.5% | -3.3% | +1.6% | -1.0% | +5.8% | -2.6% | +20.4% | -1.1% | +6.6% | +12.5% | +23.3% | +7.8% | +6.1% | +40.5% | +16.7% | +3.1% | +7.7% | -10.9% | +24.6% | +4.9% | +10.2% | -0.3% | +3.6% | +1.2% | +2.8% | -2.1% | – | |
| – | -0.6% | +13.1% | -0.2% | -12.9% | +10.3% | +25.9% | -4.3% | +13.7% | +22.5% | +85.5% | -79.7% | +149.0% | +3.0% | +0.2% | -5.6% | -0.3% | -6.3% | +25.5% | -3.9% | -2.9% | +16.8% | +38.4% | -19.8% | +29.8% | +26.5% | +15.8% | -11.2% | +21.1% | +17.6% | +11.6% | -20.8% | +23.0% | +25.1% | +12.3% | -17.2% | +67.3% | -15.5% | +3.0% | -7.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +128.9% | +7.9% | -3.0% | -2.9% | +1.9% | -0.1% | +2.8% | -2.4% | +24.7% | -3.7% | +1.0% | +20.1% | +22.2% | +4.6% | +4.2% | +52.2% | +16.1% | +1.1% | +7.0% | -9.3% | +24.8% | +2.0% | +9.8% | +2.8% | -5.6% | +5.6% | +2.8% | -1.0% | – | |
| – | -0.6% | +13.1% | -0.2% | -12.9% | +10.3% | +25.9% | -4.3% | +13.7% | +22.5% | +85.5% | -60.7% | +39.9% | -0.7% | +37.2% | -33.1% | +3.0% | -13.8% | +11.4% | -28.0% | +48.0% | +0.8% | +11.3% | -31.8% | +17.0% | +108.6% | -50.7% | -13.0% | +11.0% | +2,015.9% | -97.6% | +30.9% | +15.7% | +10.0% | +15.7% | +2.3% | +12.1% | -39.0% | -32.0% | +47.3% | – | |
| – | -38.4% | +5.2% | +24.9% | -7.3% | -7.4% | +31.6% | +26.9% | -1.6% | +38.5% | +90.1% | +21.5% | -51.2% | -17.3% | +235.8% | -62.7% | +22.4% | -15.4% | +54.1% | +3.7% | -21.2% | +1.5% | -6.7% | +83.5% | -41.4% | +7.3% | +12.8% | +74.7% | -15.6% | +17.8% | +10.3% | +65.0% | -33.0% | +199.5% | -68.8% | +227.7% | -4.7% | +5.5% | -55.5% | +148.8% | – | |
| – | -18.7% | +10.2% | +8.5% | -10.7% | +3.0% | +28.0% | +7.7% | +6.8% | +29.1% | +87.5% | -23.6% | +16.1% | -7.0% | +39.9% | -19.4% | +6.3% | -9.5% | +27.6% | -10.3% | +1.6% | +4.1% | +9.5% | +8.9% | -14.8% | +33.0% | -16.5% | +112.2% | +2.6% | +207.8% | -57.8% | +10.9% | -9.9% | +10.3% | -2.0% | +4.9% | -16.4% | +12.9% | +13.9% | -19.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +26.3% | -42.2% | +33.6% | -3.9% | +13.8% | -26.4% | +13.7% | +61.6% | -11.6% | -9.0% | +36.3% | +64.5% | -12.1% | +22.7% | +15.6% | +31.1% | -179.6% | – | -34.9% | +100.0% | -6.2% | +23.4% | +0.8% | +4.6% | 0.0% | -6.7% | +18.4% | – | |
| – | -27.8% | -34.4% | +150.3% | -17.2% | +41.8% | -3.9% | +88.2% | +58.7% | -7.3% | 0.0% | -0.1% | +31.2% | -12.7% | +1.3% | -15.7% | – | – | – | – | – | – | – | – | +248.4% | +179.3% | +211.8% | -39.6% | – | – | +543.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +24.8% | -41.0% | +31.3% | -5.8% | +12.9% | -25.7% | +13.3% | +60.9% | -11.5% | -8.9% | +36.3% | +61.8% | -7.9% | +26.9% | +13.0% | +30.0% | -178.4% | – | -37.7% | +91.8% | +2.5% | +29.7% | -3.9% | -2.8% | +2.5% | +1.2% | +17.1% | – | |
| – | – | -211.2% | – | -152.9% | – | – | – | – | – | – | – | – | +35.3% | -21.8% | +28.2% | +0.5% | -5,254.0% | – | – | +67.6% | +0.6% | -6.4% | +20.4% | +57.1% | -50.8% | +131.3% | +2.8% | +38.8% | -167.5% | – | -51.0% | +157.9% | -11.2% | +37.0% | -20.3% | +18.1% | +6.2% | +5.2% | +6.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +24.4% | -41.8% | +31.5% | -6.2% | +343.1% | -73.6% | -33.0% | +59.0% | -15.2% | -9.9% | +42.2% | +63.3% | +5.2% | +12.0% | +16.1% | +27.7% | -181.5% | – | -33.2% | +75.3% | +7.6% | +27.5% | +1.4% | -8.2% | +1.3% | -0.2% | +20.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +26.3% | -40.2% | +30.2% | +1.8% | +7.0% | -26.3% | +14.4% | +61.0% | -11.5% | -8.4% | +35.4% | +61.7% | -6.1% | +16.0% | +42.6% | +30.0% | -151.1% | – | -31.0% | +69.3% | +2.2% | +25.5% | -3.5% | -2.5% | +2.2% | +1.2% | +15.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.